• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Joe V. Selby Considers Unanswered Questions of Approved Treatments

Video

When treatments get in the marketplace and are being recommended and used, there are actually still a lot of questions that can only be answered by researching real-world data, explained Joe V. Selby, MD, MPH, executive director of the Patient-Centered Outcomes Research Institute.

When treatments get in the marketplace and are being recommended and used, there are actually still a lot of questions that can only be answered by researching real-world data, explained Joe V. Selby, MD, MPH, executive director of the Patient-Centered Outcomes Research Institute.

Transcript (slightly modified for readability)

How can the healthcare industry encourage and get patients more engaged in shared decision making?

Probably the first thing that needs to happen in the United States is we need to admit that there are a lot of questions that haven't been answered; that many times a physician makes a recommendation, it's really based on inadequate evidence. "We think this will do better for you, it's done better for other people on average."

So there's still a lot of unanswered questions about whether treatments that looked "better" in randomized trials for approval actually always behave better for all patients once these treatments are in the marketplace and being recommended and used.

There's a lot more detail that can only be learned after treatments are in the marketplace or the real world, and the Patient-Centered Outcomes Research Institute funds research that leads to understand exactly that: how are these treatment choices playing out in real-world settings, and do they work the same for everybody?

Related Videos
Chesahna Kindred, MD, MBA, FAAD, board-certified dermatologist, Kindred Hair & Skin Center.
Debra Boyer, MD, MHPE, ATSF.
Video 2 - "Payer Needs and Strategies for Evaluating and Covering PDTs"
Video 1 - "Differentiating PDTs from Wellness Apps and Evaluating Efficacy"
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
Plasminogen is vital in the body's coagulation process and breaking down clots | image credit: peterschreiber.media - stock.adobe.com
ISPOR 2024 Recap
Chris Pagnani, MD, PC
Video 4 - "Oral SERDs in Development for ER+/HER2- Metastatic Breast Cancer"
Video 3 - "The Role of Oral SERDs in ER+/HER2- Metastatic Breast Cancer"
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.